Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

NCT01599793 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Bone Metastases
Castrate-resistant Prostate Cancer
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: cabozantinib
OTHER: laboratory biomarker analysis
PROCEDURE: magnetic resonance imaging

Sponsor

University of Chicago

Collaborators

[object Object]